Authors:
WALDHAUSER F
KISSLING E
ANSORGE J
MUELLER S
Citation: F. Waldhauser et al., 3-DIMENSIONAL INTERFACE MODELING WITH 2-DIMENSIONAL SEISMIC DATA - THE ALPINE CRUST-MANTLE BOUNDARY, Geophysical journal international, 135(1), 1998, pp. 264-278
Authors:
BIRNBACHER R
SCHEIBENREITER S
BLAU N
BIEGLMAYER C
FRISCH H
WALDHAUSER F
Citation: R. Birnbacher et al., HYPERPROLACTINEMIA, A TOOL IN TREATMENT CONTROL OF TETRAHYDROBIOPTERIN DEFICIENCY - ENDOCRINE STUDIES IN AN AFFECTED GIRL, Pediatric research, 43(4), 1998, pp. 472-477
Authors:
HEINEMANN LAJ
WILLSHAHAB L
VANKESTEREN P
GOOREN LJG
QUAST A
PIETSCH H
KONRAD N
HELGE H
GRUTERS A
KNAPPE G
VENTZ M
PRANGE G
UBELHACK R
BANASCHAK K
CAVALLARI C
MACRELLI S
HINKEL GK
JUSTUS B
SAREMBE B
ABUSCHENKO E
MOESLER T
SCHINDLER AE
REGIDUR PA
MADJIDIAN K
BRAENDLE LW
KLEINKAUFHOUCKEN A
HORN HJ
MICHEL W
MORLOT M
VEISMANN S
ZIEGLER R
KREMPIEN R
ALENFELD F
HEINRICH U
SIPPELL WG
WILLE R
LASCHET R
ALEXANDER H
GLANDER HJ
SCHWARZE I
HOEPFFNER W
DIEDRICH K
SCHILL T
HEISE HR
LEHNERT H
SCHLICHTHAAR H
WEISE W
GERLOFF C
NICKEL I
BURMANNREUTER H
KRAUSE W
FLOHR J
PLEWIG G
WOLF H
SCHWARZ HP
BECKER A
SCHMIDT C
SIEGELALMASRY E
MIX M
OTTERMANN B
RANKE MB
GRAUER ML
TELLER W
HOMOKI J
WALDHAUSER F
KAISER E
BALJER E
EIDEN R
OTT F
Citation: Laj. Heinemann et al., SAFETY OF CYPROTERONE-ACETATE - REPORT OF ACTIVE SURVEILLANCE, Pharmacoepidemiology and drug safety, 6(3), 1997, pp. 169-178
Citation: F. Waldhauser, MELATONIN - NEW FASHIONABLE DRUG OR SUBSTANCE WITH DEFINITE ACTIVITY, Wiener Klinische Wochenschrift, 109(18), 1997, pp. 705-706
Authors:
VANLIEBURG AF
VERDIJK MAJ
SCHOUTE F
LIGTENBERG MJL
VANOOST BA
WALDHAUSER F
DOBNER M
MONNENS LAH
KNOERS VVAM
Citation: Af. Vanlieburg et al., CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS IN FEMALES - CLINICAL CONSEQUENCES OF HETEROZYGOSITY FOR A VASOPRESSIN TYPE-2 RECEPTOR MUTATION, Kidney international, 50(1), 1996, pp. 335-335
Authors:
VANLIEBURG AF
VERDIJK MAJ
SCHOUTE F
LIGTENBERG MJL
VANOOST BA
WALDHAUSER F
DOBNER M
MONNENS LAH
KNOERS VVAM
Citation: Af. Vanlieburg et al., CLINICAL PHENOTYPE OF NEPHROGENIC DIABETES-INSIPIDUS IN FEMALES HETEROZYGOUS FOR A VASOPRESSIN TYPE-2 RECEPTOR MUTATION, Journal of the American Society of Nephrology, 6(3), 1995, pp. 728-728
Authors:
VANLIEBURG AF
VERDIJK MAJ
SCHOUTE F
LIGTENBERG MJL
VANOOST BA
WALDHAUSER F
DOBNER M
MONNENS LAH
KNOERS NVAM
Citation: Af. Vanlieburg et al., CLINICAL PHENOTYPE OF NEPHROGENIC DIABETES-INSIPIDUS IN FEMALES HETEROZYGOUS FOR A VASOPRESSIN TYPE-2 RECEPTOR MUTATION, Human genetics, 96(1), 1995, pp. 70-78
Authors:
HOFMANNEHRHART B
SCHULZ U
KLUGE M
WANDLVERGESSLICH K
WALDHAUSER F
Citation: B. Hofmannehrhart et al., PROLONGED EXPERIENCE WITH A LONG-ACTING G ONADOTROPIN-RELEASING-HORMONE ANALOG IN THE TREATMENT OF CENTRAL PRECOCIOUS PUBERTY - EFFECT ON GROWTH, Wiener Klinische Wochenschrift, 107(14), 1995, pp. 413-417
Authors:
DJURHUUS JC
KRIEGER J
HOMSY Y
WALDHAUSER F
Citation: Jc. Djurhuus et al., HORMONAL-CONTROL OF SODIUM AND WATER-EXCRETION IN OBSTRUCTIVE SLEEP-APNEA - DISCUSSION, Scandinavian journal of urology and nephrology, 1995, pp. 68-69
Authors:
KOFF SA
RITTIG S
DJURHUUS JC
WALDHAUSER F
WARSHAW BL
Citation: Sa. Koff et al., AGE-RELATED-CHANGES IN THE CIRCADIAN CONTROL OF URINE OUTPUT - DISCUSSION, Scandinavian journal of urology and nephrology, 1995, pp. 74-75
Authors:
CHEGINI S
EHRHARTHOFMANN B
KAIDER A
WALDHAUSER F
Citation: S. Chegini et al., DIRECT ENZYME-LINKED-IMMUNOSORBENT-ASSAY AND A RADIOIMMUNOASSAY FOR MELATONIN COMPARED, Clinical chemistry, 41(3), 1995, pp. 381-386
Citation: F. Waldhauser et al., CLINICAL ASPECTS OF THE MELATONIN ACTION - IMPACT OF DEVELOPMENT, AGING, AND PUBERTY, INVOLVEMENT OF MELATONIN IN PSYCHIATRIC DISEASE AND IMPORTANCE OF NEUROIMMUNOENDOCRINE INTERACTIONS, Experientia, 49(8), 1993, pp. 671-681
Authors:
RODEN M
KOLLER M
PIRICH K
VIERHAPPER H
WALDHAUSER F
Citation: M. Roden et al., THE CIRCADIAN MELATONIN AND CORTISOL SECRETION PATTERN IN PERMANENT NIGHT-SHIFT WORKERS, The American journal of physiology, 265(1), 1993, pp. 180000261-180000267